TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02483793

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamsulosin

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxybutynin
Study: NCT03420755

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mothers and Babies 1-on-1
Description: MB 1-on-1 is a 12-session intervention divided into five modules. An introductory 2-session module establishes key concepts related to stress, monitoring of one's mood, and ways in which one's mood influences one's internal thoughts and external environment; three 3-session modules correspond with key cognitive-behavioral elements: pleasant activities, thoughts, and social support/contact with others; a 1-session summary reviews content and identifies areas for future use of MB skills. Throughout MB, mood management skills are integrated using psycho-educational activities that encourage participants to understand connections between their mood and their activities, thoughts, and contacts with others.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mothers and Babies Plus Text
Description: MB 1-on-1 along with text enhancements, both in English and Spanish. These texts focus on: a) skill reinforcement (e.g., Some thoughts just come to us, but we can make a conscious effort to think of positive thoughts.); b) homework reminders (e.g., What pleasant activity will you try today?), and c) self-monitoring (e.g., On a scale of 1-9, how would you rate your mood?). These texts will be linked with the 12 MB sessions. Specifically, after completing each in-person session, 3 texts will be sent by a home visitor to her client; one text will focus on skill reinforcement, one will be a homework reminder, and one will focus on self-monitoring.
Study: NCT00956007

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: intravenously

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: intensity-modulated radiation therapy
Description: daily fractions

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: daily fractions
Study: NCT03203811

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTI-2088
Description: 3 dose levels
Study: NCT00488566

Intervention type: DRUG
Group type: OTHER
Intervention: GSK drug
Description: GSK drug
Study: NCT03203811

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTI-2088
Description: 3 dose levels

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HTI-2088
Description: 3 dose levels

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo oral tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo oral tablet
Study: NCT00711048

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1386
Description: oral, single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1386
Description: oral, single dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral solution, single dose
Study: NCT03195218

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HRME examination
Description: HRME will capture images from all areas considered abnormal by VIA and/or colposcopy. In addition, all four quadrants will be probed with HRME to ensure that any non-acetowhite lesions are also observed
Study: NCT03865433

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: Sub-symptom threshold aerobic exercise at a dose of 30 minutes per day, five days per week.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo/Stretching
Description: A detailed, progressive stretching program to be performed for approximately 20-30 minutes per day, five days per week
Study: NCT03629665

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Intensive Language-Action Therapy (ILAT)
Description: ILAT includes communicative language games played in an interactive small-group setting. Three persons with aphasia and one therapist sit around a table and have picture cards in front of them. The card sets include two items of each object or action picture. All participants take turns in making verbal requests. There will be 5 daily sessions (3 hours per session) for two weeks.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Intensive Language-Action Therapy (ILAT)
Description: ILAT includes communicative language games played in an interactive small-group setting. Three persons with aphasia and one therapist sit around a table and have picture cards in front of them. The card sets include two items of each object or action picture. All participants take turns in making verbal requests. There will be 5 daily sessions (3 hours per session) for two weeks.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive navigated Transcranial Magnetic Stimulation during naming training
Description: Magnetic stimulation will delivered with a figure-of-eight cooled coil of Navigated Brain Stimulation System during picture naming training. The primary targeted area is the right pars triangularis. In each session, rTMS will be applied at 1-Hz for 20 minutes, 5 daily sessions per week for four weeks.
Study: NCT02066948

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Meal Pattern
Description: Even or skewed distribution of protein for a 16 week period of wt loss.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Meal Pattern
Description: Even or skewed distribution of protein for a 16 week period of wt loss.
Study: NCT03844672

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Power
Description: Participants will receive a low power e-cigarette to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Power
Description: Participants will receive a low power e-cigarette to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Power
Description: Participants will receive a high power e-cigarette to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Power
Description: Participants will receive a high power e-cigarette to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Concentration
Description: Participants will receive a low concentration e-liquid to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Concentration
Description: Participants will receive a low concentration e-liquid to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Concentration
Description: Participants will receive a high concentration e-liquid to use for 3 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Concentration
Description: Participants will receive a high concentration e-liquid to use for 3 weeks
Study: NCT00488566

Intervention type: DRUG
Group type: OTHER
Intervention: GSK drug
Description: GSK drug

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: Placebo

Intervention type: OTHER
Group type: OTHER
Intervention: Lamictal
Description: Positive control
Study: NCT04989842

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Curriculum Hannover
Description: The methodology uses a natural variation design within the Dr. Becker Clinical Group. The interventions consist of a face-to-face or a digital psychosomatic aftercare basing upon the concept of the Curriculum Hanover. A control group is included that does not receive these two interventions (but receives a similar rehabilitation treatment to the intervention groups).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Curriculum Hannover
Description: The methodology uses a natural variation design within the Dr. Becker Clinical Group. The interventions consist of a face-to-face or a digital psychosomatic aftercare basing upon the concept of the Curriculum Hanover. A control group is included that does not receive these two interventions (but receives a similar rehabilitation treatment to the intervention groups).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Curriculum Hannover
Description: The methodology uses a natural variation design within the Dr. Becker Clinical Group. The interventions consist of a face-to-face or a digital psychosomatic aftercare basing upon the concept of the Curriculum Hanover. A control group is included that does not receive these two interventions (but receives a similar rehabilitation treatment to the intervention groups).
Study: NCT01023698

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laser photocoagulation
Description: Laser photocoagulation
Study: NCT01579318

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tavokinogene Telseplasmid (tavo)
Description: Patients received intratumoral injection(s) of tavo.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OncoSec Medical System (OMS)
Description: Electroporation via OMS was performed immediately following intratumoral injection of tavo. A sterile applicator containing 6 stainless steel electrodes arranged in a circle were placed around the tumor. The applicator was connected to the OMS power supply and six pulseswere administered to each tumor lesion at the approximate point of tavo injection.
Study: NCT02401776

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Coffee
Description: Coffee. This will be given at a dose of 2mg caffeine/kg body weight (equivalent to approximately one 8 ounce cup of coffee drink for a person weighing 75 kg).
Study: NCT02347332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinflunine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Study: NCT02432066

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GTS-21
Description: GTS-21 is a partial alpha7 nicotinic agonist. GTS-21 will be compounded by the UF investigational pharmacy, and administered orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo pills, compounded by the UF investigational pharmacy
Study: NCT04082507

Intervention type: DIAGNOSTIC_TEST
Intervention: Serum alpha-fetoproteine
Description: Midtrimesteric serum alpha-fetoprotein mesurment with 2D US and 3D power Doppler with MS US scan .
Study: NCT03387826

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor 60 mg
Description: Ticagrelor 60 mg twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg
Description: Ticagrelor 60 mg twice daily
Study: NCT02105168

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Optional

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tumorous biopsy
Description: Optional

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Healthy material sample
Description: Optional
Study: NCT01188785

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: siG12D LODER
Description: Phase 0 - subjects diagnosed with an operable adenocarcinoma of the pancreas will have 8 siG12D LODER placed in tumor. The siG12D LODER will be placed in the subject's tumor using an EUS biopsy needle.~Phase I - subjects diagnosed with locally non-operable advanced adenocarcinoma of the pancreas. These subjects will have one of three different siG12D LODERs dose levels placed in tumor - Either 1 siG12D LODER, 2 siG12D LODERs or 8 siG12D LODERs. The siG12D LODER/s will be placed in the subject's tumor using an EUS biopsy needle.
Study: NCT06410729

Intervention type: OTHER
Intervention: Observational study, no intervention

Intervention type: OTHER
Intervention: Observational study, no intervention

Intervention type: OTHER
Intervention: Observational study, no intervention
Study: NCT05202184

Intervention type: PROCEDURE
Intervention: Percutaneous thermal ablation
Description: All thermoablation procedures were performed percutaneously under ultrasound and/or CT guidance
Study: NCT01551628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human arginase 1 Peg5000
Description: Patients will receive weekly IV infusions of PEG-BCT-100, until evidence of disease progression, intolerable adverse events, or withdrawal of patient consent. For safety sake, each subject will receive an induction dose of PEG-BCT-100 500 U/kg and 1000 U/kg at week -2 and week -1, respectively. The study dose of PEG-BCT-100 1600 U/kg will be initiated at week 1 (Day1). Each escalation of dose level will be determined by the investigator according to each subject's tolerability and criteria for treatment discontinuation.
Study: NCT01430910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAZ104
Description: IV infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avibactam
Description: IV infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ceftazidime
Description: IV infusion
Study: NCT04366089

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oxygen-ozone therapy, probiotic supplementation and Standard of care
Description: - systemic autohemotherapy with Ozone 30 mcg / ml 250ml 2 times / day for 7 days
Study: NCT01308671

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling and psychosocial support
Description: Blank group will receive the same counseling and psychosocial support as varenicline group
Study: NCT00880828

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FIR cervical collar with Acetaminophen
Description: FIR cervical collar with Acetaminophen QID/PRN for 4 weeks
Study: NCT04366089

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SivoMixx (200 billion)
Description: Composition of SivoMixx: Streptococcus thermophilus DSM322245, Bifidobacterium lactis DSM 32246, Bifidobacterium lactis DSM 32247, Lactobacillus acidophilus DSM 32241, Lactobacillus helveticus DSM 32242, Lactobacillus paracasei DSM 32243, Lactobacillus plantarum DSM 32244, Lactobacillus brevis DSM 27961 (NB: DSM n°... : bacterial strain identification code)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: dose: 500mg 1 cp / day (alternatively lopinavir/ritonavir cps 200/50 mg, 2 cps x 2 / day or darunavir 800 mg 1 cp / day + ritonavir 100 mg 1 cp / day or darunavir/cobicistat 800/150 mg 1 cp / day)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin
Description: dose: 500mg 1 cp / day (alternatively lopinavir/ritonavir cps 200/50 mg, 2 cps x 2 / day or darunavir 800 mg 1 cp / day + ritonavir 100 mg 1 cp / day or darunavir/cobicistat 800/150 mg 1 cp / day)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydroxychloroquine
Description: dose: 200 mg, 1 cp x 2 / day

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hydroxychloroquine
Description: dose: 200 mg, 1 cp x 2 / day
Study: NCT02429206

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SQIN
Description: Each patient will be asked to self-apply both creams (experimental vs positive control) on the right and left sides of their body (sides will be randomly assigned).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard moisturizing cream (Glaxal Base)
Study: NCT03686527

Intervention type: PROCEDURE
Intervention: stenosis aortic valve
Description: The exams to be realized :~* a clinical examination with blood pressure~* a 12-lead surface electrocardiogram~* a standard biological assessment including NTproBNP (Brain Natriuretic Peptide)~* Transthoracic echocardiography at baseline and 12 months after the aortic valve intervention on the (according to recommendations)~* a cardiac MRI looking for fibrosis myocardial

Intervention type: PROCEDURE
Intervention: stenosis aortic valve
Description: The exams to be realized :~* a clinical examination with blood pressure~* a 12-lead surface electrocardiogram~* a standard biological assessment including NTproBNP (Brain Natriuretic Peptide)~* Transthoracic echocardiography at baseline and 12 months after the aortic valve intervention on the (according to recommendations)~* a cardiac MRI looking for fibrosis myocardial
Study: NCT00716040

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social-psycho intervention to improve adherence to HAART
Description: The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: The control group will be submitted to the usual care of the health service
Study: NCT01945190

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Study: NCT02871570

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivipansel
Description: A single dose of IV Rivipansel over 20 minutes

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivipansel
Description: A single dose of IV Rivipansel over 20 minutes
Study: NCT03491475

Intervention type: DRUG
Intervention: Ajmaline test
Description: Administration of Ajmaline

Intervention type: DRUG
Intervention: Ajmaline test
Description: Administration of Ajmaline
Study: NCT04838340

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standart care
Description: This group will leave in the hospital's usual care and no intervention will be applied.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypnobirthig training
Description: Hypnobirthing training of the Hypnobirthing group will carry out with its partner. Hypnobirthig training will be given in small groups of 5 or 6 couples for 4 weeks and 3 hours a week. In addition, the usual care will be provided by healthcare professionals to this group.~Breathing, relaxation exercises, birth stories and birth videos will be used to reduce fears of chlildbirt women.~Deepening and endorphin massage techniques will be given for labor pain. After the endorphin massage technique will be applied individually by the researcher, it will be applied by the couples and they will ask for repeating all exercises at home.~In the last week of the training, there will be a birth rehearsal with Hynobirthing methods with the partners.~The second meeting will take place when labor begins and after labor.
Study: NCT03500536

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IntelliCare
Description: A suite of mobile apps that use principles of computerized therapy to decrease symptoms of depression.
Study: NCT03013426

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVX-508
Description: Administration of NVX-508 emulsion intravenously
Study: NCT02292524

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Commercially-available tomato food product
Description: Each of the three tomato food products (juice, soup, sauce) provided 25-35 mg lycopene/day.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Commercially-available tomato food product
Description: Each of the three tomato food products (juice, soup, sauce) provided 25-35 mg lycopene/day.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Commercially-available tomato food product
Description: Each of the three tomato food products (juice, soup, sauce) provided 25-35 mg lycopene/day.
Study: NCT03387826

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prasugrel 5mg
Description: Prasugrel 5 mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel 5mg
Description: Prasugrel 5 mg once daily
Study: NCT00880828

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative cervical collar with Acetaminophen
Description: Conservative cervical collar with Acetaminophen QID/PRN for 4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Acetaminophen only
Description: Acetaminophen QID/PRN for 4 weeks
Study: NCT00813735

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eszopiclone
Description: Eszopiclone 2mg daily at bedtime

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo daily at bedtime

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Escitalopram
Description: Escitalopram 10mg or 20mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Escitalopram
Description: Escitalopram 10mg or 20mg
Study: NCT01841983

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Be Well Work Well
Description: The intervention follows principles for integrated approaches to promoting and protecting worker health. It will occur on 4 inpatient units at Massachusetts General Hospital beginning in January 2013, and will continue for 1 year.~Overall intervention objectives:~1. Motivate individual staff members to engage in targeted health and safety behavior changes;~2. build awareness of ergonomic and safety hazards and of opportunities for healthy dietary choices and physical activity;~3. facilitate unit-level norms supportive of breaks, safe patient handling, and targeted health and safety behaviors; and~4. promote co-worker and supervisor support for targeted health and safety behaviors.
Study: NCT01025752

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Face to face cognitive behavior therapy
Description: Ten session face to face cognitive behavior therapy for chronic low back pain

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IVR based cognitive behavioral therapy
Description: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy
Study: NCT03067168

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: 5 mL of 0.5% bupivacaine will be injected into 2 locations bilaterally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline 0.9%
Description: 5 mL of 0.9% normal saline will be injected into 2 locations bilaterally.